Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Patrick Heron


  • Large Shareholder, Director at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-17
  • Large Shareholder, Director at Iterum Therapeutics Plc (ITRM), 2019-06-17
  • Large Shareholder at Alpine Immune Sciences Inc. (ALPN), 2019-01-22
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Aptinyx Inc. (APTX), 2018-06-26
  • Large Shareholder at Anaptysbio Inc (ANAB), 2018-05-15
  • Large Shareholder at Sierra Oncology Inc. (SRRA), 2017-02-24
  • Director at Tobira Therapeutics Inc. (TBRA), 2016-11-03
  • Large Shareholder, Director at Collegium Pharmaceutical Inc (COLL), 2015-09-14
  • Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
  • Director at Cidara Therapeutics Inc. (CDTX), 2015-04-22
  • Director, Other at Trubion Pharmaceuticals Inc (TRBN), 2010-10-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ITRM $13.00 101,150 Large Shareholder, Director 341,155 2018-05-30 Filing
ITRM $13.00 354,949 Large Shareholder, Director 1,197,161 2018-05-30 Filing
COLL $12.00 150,000 Large Shareholder, Director 1,887,332 2015-05-12 Filing
CDTX $16.00 44,355 Director 44,355 2015-04-20 Filing
CDTX $16.00 155,645 Director 155,645 2015-04-20 Filing